Switzerland-based MedAlliance, a company producing drug-eluting balloons (DEBs), has raised $50m in a private equity round. The investor is Trustar Capital.
The proceeds will fund commercialization of its SELUTION SLR balloon, and support four new FDA investigational device exemption studies this year.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?